Study of 600,000 US military veterans shows that those who took anti-obesity medications were less likely to develop some complications of substance-use disorders.

New research suggests the weight-loss medications could be powerful tools in tackling substance use disorders.

A large study of data from Veterans Affairs finds that people on GLP-1 drugs were less likely to develop substance abuse disorder or overdose.

Al-Aly and his colleagues found that people starting the GLP-1 drugs had lower risks of developing addiction to multiple ...

At the Pacific Neuroscience Institute in Santa Monica, scientists are eager to explore whether a psychedelic chemical found in a toad could help people whose depression has not eased with typical ...

Researchers at Washington University School of Medicine in St. Louis have shown in a new study that GLP-1 medications may be effective at treating and preventing substance-use disorders across all ...

Preclinical studies in animals have already shown that GLP-1 drugs can reduce reward-seeking behavior. Early clinical work in humans has begun to hint at similar effects. A randomized trial of ...

GLP-1 agonist medications such as Ozempic have been game changers in the treatment of obesity and diabetes. Recently, a new study found evidence that Ozempic may be a promising medicine for ...

The invention of social media’s never-ending scroll birthed an unforeseen addiction to the internet, and now, researchers are attempting to measure screen dependency in new studies. Scientists from ...

A new study from a team of researchers in Canada is offering one of the largest portraits to date of global smartphone use. Surveying thousands of people across nearly 200 countries the study found ...

In today’s modern society, students face multiple academic pressures. The best colleges and universities require the best grades for entry and parents push and expect their children to succeed ...